Monday, November 26, 2018

Read the Latest in USAID's Global Health News

Read the November 2018 Global Health Newsletter on One Health & Antimicrobial Resistance
Facebook

  Join Global Health on

Twitter

Follow Global Health on

Global Health News

November 2018

Hand with Pills

One Health and Antimicrobial Resistance

Zoonotic and antimicrobial-resistant (AMR) diseases account for more than 95 percent of all emerging infectious diseases reported during the second half of the 20th century. About 700,000 people die annually as a result of drug-resistant infections caused by tuberculosis (TB), HIV and malaria alone. If no action is taken, it is estimated that drug-resistant infections will kill 10 million people a year by 2050. This scenario has the potential to devastate economies, with an estimated output loss of $100 trillion by 2050. During November, partners around the world came together to acknowledge One Health Day and Antimicrobial Resistance Awareness week. This month's newsletter highlights our work combating AMR; building on the strides made against infectious diseases like TB, HIV, and malaria; and the Bureau for Global Health's multi-sectoral focus on animal, human and environmental health. Read more.


GHSA researchers work on AMR medicines.

GHSA-USAID Commitments to Addressing AMR through a One Health Approach through 2024

USAID is combating the spread and threat of zoonotic diseases and AMR by supporting the World Health Organization's Global Action Plan on AMR and the Global Health Security Agenda. The Agency also works with partner governments, academia and the private sector to support the development of national action plans on AMR; monitoring of medicine safety, effectiveness and quality; and supporting AMR and zoonotic disease surveillance systems. Read the full story.

A cow and some chickens battle zoonotic diseases.

The Monetary Impact of Zoonotic Diseases

The use of antimicrobial drugs in humans and animals has expanded such that bacteria, fungi, viruses and parasites resistant to existing antibiotics are emerging at an increasing rate. In many countries, there is minimal regulation and documentation of antimicrobial use in animal production. If we are to prevent antimicrobial-resistant infections in humans and animals, we must establish monitoring systems for AMR and develop regulations that promote the prudent use of antimicrobials in livestock production. Read the full story.

A researcher examines safe medicines.

Getting Safe Medicines to the Patients Who Need Them

Learn how USAID is looking at Indonesia's health system comprehensively to understand how to engage communities, strengthen primary health care and improve pharmaceutical quality to mitigate the threat of antimicrobial resistance and the spread of infectious disease. Read the full story.

Media Mentions

USAID Launches 5-Year, $200M Program To Control, Eliminate 5 NTDs In 11 West African Countries

It's Feared Congo's Ebola Outbreak Will Get Even Worse

The Vital Role of Early-innovation Funders

Medicines Shouldn't Make People Sicker — Protecting People from Poor-quality Meds

The Fight Against Malaria Has Reached a Standstill


Look Ahead

November 26, 2018
One Health in the 21st Century

November 27-28, 2018
Readiness for Microbial Threats 2030: Exploring Lessons Learned Since the 1918 Influenza Pandemic

November 29, 2018
Diagnostic Stewardship: Webinar of the WHO AMR Surveillance and Quality Assessment Collaborating Centre Network Series

December 1, 2018 
World AIDS Day


The KMS Project is sending these announcements on behalf of USAID's Bureau for Global Health. The KMS Project is located at 1300 Pennsylvania Ave, NW, Suite 440, Washington DC 20004  • (202) 660-1860 GovDelivery logo

No comments:

Post a Comment